Summary
M RL-~r///r mice develop a spontaneous autoimmune dis-. ease characterized by lymphadenopatby, autoantibody production, and inflammatory manifestations including nephritis, vasculitis, and arthritis (1, 2) . Immune function abnormalities also include enhanced constitutive macrophage class II antigen expression (3) , devated levels of IFN-% TNF, IL-1, and IL-6 in isolated kidney, lymph node, and spleen ceils (4) (5) (6) , and an enhanced state of macrophage "activation" (3, 7) . These disease manifestations are a result of both a single gene mutation (I/r) of the Fas apoptosis gene on mouse chromosome 19 (8, 9) and background genes from the MRL swain (1, 9) . Although the MILL genes contributing to disease manifestations have not been identified, two loci contributing to renal disease have been mapped to regions of mouse chromosomes 7 and 12 (9) .
We have hypothesized that nitric oxide (NO) 1 plays a role in the pathogenesis of disease in MRL-lpr/Ipr mice. NO, a multifunctional molecule produced by diverse cell types, results from the conversion of L-arginine to t-dtrulline and NO by the action of the enzyme nitric oxide synthase (NOS). NO has been noted to promote relaxation of smooth muscle, serve as a neurotransmitter, cause staffs and/or lysis of microbes and tumor cells, and modulate function and differentiation of hematopoietic cells (10) (11) (12) (13) (14) . NO also has potent proinflammatory actions. Cell-derived NO, through interaction with superoxide, forms peroxynitrite which in turn may spontaneously produce hydroxyl radical, a molecule with high potential for cell and tissue injury and destruction (15) (16) (17) . NO may increase vascular permeability in inflamed tissues (18) . NO has also been shown to cause increased expression of TNF and IL-1 by cells, and to increase the potential of cells to produce hydrogen peroxide (13, 14) . Also, rabbit and human chrondrocytes have been shown to produce NO and to express iNOS in response to various cytokines and bacterial products (19, 20) , and investigators have noted increased concentrations of the NO catabolite nitrite in synovial fluid and sera of patients with inflammatory arthritis (21) . McCartneyFrancis et al. (22) have recently demonstrated that rats with arthritis induced by injection of streptococcal cell wall fragments have increased production of NO, and that administration of an inhibitor of NO synthase suppresses the arthritis.
In the current studies, we have investigated the role of NO in lpr spontaneous autoimmune disease and determined the chromosomal location of iNOS. Results demonstrate that
MtLL-lpr/Ipr mice have devated levels of urinary excretion
of nitrite/nitrate (a marker of NO production), and that their macrophages have an enhanced capacity for NO production.
Certain tissues from MRL-lpr/Ipr mice have increased NOS activity, increased expression of iNOS mtLNA, and increased amounts of material immunoreactive for iNOS. Furthermore, blocking NO production with N~-monomethyl-t-arginine (NMMA) prevents the development oflnflanamatory nephritis and arthritis in these mice. As determined by interspecific ha&cross experiments, the gene for iNOS maps to mouse chromosome 11. This position is different from the location of Fas and those loci that we have previously demonstrated to be significantly linked to susceptibility to renal disease in Nitrite/Nitrate Assay. Mice were housed in metabolic cages (three per cage) and fed deionized distilled sterile water and a defined 652 Nitric Oxide in Spontaneous arginine and nitrate-free diet as noted before (23) . Urine was collected into isopropanol to inhibit bacterial growth. Urinary nitrite/nitrate concentration was determined spectrophotometrically as described before (23) . Determinations were done in duplicate or triplicate. Total nitrate excretion was then calculated based on the concentration and the urine volume. NOS Assay. Spleen, fiver, kidneys, lymph nodes, and peritoneal cells were collected and quickly frozen in a dry ice-ethanol slurry in a buffer-protease inhibitor cocktail containing 100/~M pbenylmethylsulfonyl fluoride, 5/~g/ml aprotinin, 1/~g/ml chymostatin, and 5/~g/ml pepstatin A. The tissue cells were then disrupted with a pestle and repeated freeze-thaw cycles. Cytosol was collected after centrifugation, and assayed for protein and NOS activity using a modification of procedures noted before (24, 25) . The assay buffer contained 50 raM Hepes (pH 7.5), 200 /zM NADPH, 1 mM dithiothreitol, 10/zM FAD, 100/~M tetrahydrobiopterin, and 10/~M L-arginine. We used L-arginine labeled with tritium in the guanidino position (NEC-453; New England Nuclear, Boston, MA). 30 #1 of sample was used in a total reaction mixture of 50 ~1. Samples were done in duplicate or triplicate.
MRL-
Messenger RNA Analysis, Immunofluorescence, and Imrnunob/ors. Total mRNA extraction and analysis was performed as noted before (6, 14) . Indirect immunofluorescence was done as described before on tissues that were frozen quickly, sectioned, and fixed in cold acetone (26) . Guinea pig serum containing antibody specific for natural rat iNOS was from Dr. Stephen Gross (Oxford University, Oxford, England). Normal guinea pig serum served as negative control in experiments using the guinea pig antiserum. A rabbit polyclonal antiserum against murine ILAW264.7 iNOS was produced by immunization with an iNOS fusion protein expressed in Eschoichia coil cDNA encoding amino adds 1-224 of RAW264.7 iNOS was amplified by RNA-PCK as described (25, 27) , and inserted into the pGEX2T vector (Pharmacia LKB, Piscataway, NJ). Gene expression from this plasmid construct results in the production of a protein containing 26 kD of the carboxyl terminus of glutathione-S-transferase fused to amino terminus of the encoded region of RAW264.7 iNOS. The iNOS fusion protein was purified f~om E. coli by a~inity chromatography on glutathinne-Sepharose (Pharmada LKB) (28) followed by preparative SDS polyacrylamide electmphoresis. The purified iNOS fusion protein in the acryhmide gel band was directly injected into New Zealand rabbits as described (29) . Immunoprecipitates and immunoblots using the antiserum were done as described before (29) . For the immunoblots, tissue from mouse organs was frozen rapidly in liquid nitrogen. In immunoprecipitation experiments, the tissue was homogenized and extracts were precipitated with the rabbit anti-mouse iNOS antibody Chromosome Localization. C3H/HeJ-g/d and Mus spretus (Spain) mice and [(C3H/HeJ-g/d x Mus spretus)F1 x C3H/HeJ-gld] interspecific backcross mice were bred and maintained as previously described (30) . Mus spretus was chosen as the second parent in this cross because of the relative ease of detection of informative restriction fragment length variants (RFLV) in comparison with crosses using conventional inbred laboratory strains.
DNA was isolated from mouse organs by standard techniques. DNA was digested with restriction endonudeases, and 10-/zg samples were electrophoresed in 0.9% agarose gels. DNA was transferred Nytran membranes (Schl~er and Schuell, InK, Keene, NH), hybridized at 65~ and washed under stringent conditions, as previously described (31) . Clones used as probes in the current study included the mouse macrophage iNOS c.DNA (nudeotides 1-675 [27, 32] ), the avian erythroblasmsis a and b (Erba and Erbb2) cDNAs, pAEPst0.45 and pAEBam0.5, respectively (33) , and the p53 protooncogene cDNA (Trp53) (34) .
Autoimmunity
Gene |ink2ge was determined by segregation analysis (35) . Gene A 6 order was determined by analyzing all haplotypes and minimizing crossover frequency between all genes that were determined to be ~ s within a !i-kige group. This method resulted in determination of "-the most likely gene order (36 Gri~th (Medical College of Wisconsin, Milwaukee, WI). Both ~ 1 groups of mice were maintained on the defined nitrate-free diet ~-~ described above. At weekly intervals, the mice were placed in metao boric cages and 24-h urine collections were obtained. Urinary nitrate/nitrite was measured as described above, and urinary protein was measured using the Bradford assay (Bio-Rad hboratoties, Richmond, CA). After 10 wk of treatment, the mice were bled and killed with removal of the kidneys and knee joints.
, 12 Serum anti-DNA activity was determined by ELISA as previously described (37) . The kidneys were imbedded in paraffin, sectioned, and stained with hematoxylin and eosin. Knec joints were ~ 10 decalcified in formic add, embedded into paraffin, sectioned, and ~ ~. 8 stained. Slides were then read by a pathologist "blinded" as to the group of origin. The amount of kidney and lmecjoint disease present in each specimen were quantitated as noted before (38) . Briefly,
~ o e glomeruli were graded for hypercellularity (0-4), hyperlobuhrity ~ ~. 4 (0-4), crescents (0-4), and necrosis (0-4). A score was then de-
rived by adding the grading of these features of glomerular disease. Kidneys from normal BALB mice usually have scores from 0 to 1. Vasculitis was noted when present in medium size vessels in the kidney sections. The synovial score was derived by adding the grading of synovial proliferation (0-3) and subsynovial inflammation (0-3). Knee joints from normal BALB mice usually have scores from 0 to 0.5.
Results
Nitrite/Nitrate Excretion. In animals consuming a nitratefree diet, urinary excretion of nitrite/nitrate accurately reflects the endogenous production of NO (23) . To determine the production of NO in mice of different strains, we analyzed urine collected daffy under basal conditions. Fig. 1 A demonstrates that MILL-IF/I F mice excrete more nitrite/nitrate than do C3H mice, when analyzed over a 10-d period at 3 mo of age. Likewise, when analyzed over time beginning at 6 wk of age, MILL-lt,r/lpr mice excrete higher levels of nitrite/ nitrate than do B6 mice as the mice age ( Fig. 1 B) . Higher nitrate/nitrite excretion begins at '~10-12 wk of age, paralleling that of proteinuria (Fig. 1 C) . Oral administration of 50 mM NMMA in water to the MILL-lpr/llyr mice reduced the high level nitrite/nitrate excretion (see bdow). This signifies that the nitrite/nitrate is a product of NOS, since NMMA is a specific inhibitor of the enzyme (10, 12, 39 These figures show results of one set of three experiments that showed comparable results. However, in the results represented in B and C, the initial mildly elevated levels of excretion in B6 mice seen early were noted in only one of three experiments.
had no enhancement of nitrite/nitrate production when treated with endotoxin or IFN-'y alone, but the combination enhanced the production greatly. In contrast, peritoneal macrophages from MRL-Ipr/Ipr mice had enhanced responses to treatment with endotoxin and murine IFN-~/alone, as weU as with combined endotoxin/IFN-7 treatment (Fig. 2) (Fig.  4) . By immunofluorescence analysis using a rabbit anti-mouse iNOS antibody, we noted no NOS antigen expression in spleen, liver, and kidney from BALB mice, and none in liver or kidney from MRL-Ipr/Ipr mice. However, spleens from MtLL-IF/I F mice displayed large numbers of ceUs containing the NOS antigen (Fig. 5 A) . Comparable findings were noted when we used a monospecific guinea pig anti-rat inducible NOS antibody (data not shown). When tissue extracts were analyzed for iNOS antigen by immunoprecipitation and immunoblotting techniques using a rabbit anti-mouse iNOS antibody, we did not detect antigen in extracts from organs of BALB mice, although extracts from spleen and kidney tissues from MRL-Ipr/Ipr mice had readily detectable antigen (Fig. 5 B) .
NMMA Treatment. Groups of MRL-Ipr/Ipr mice received
either double distilled water (n = 10) or water containing 50 mM NMMA (n = 9) beginning at 8 wk of age. Both groups of mice received the defined nitrate free diet. Mice were treated for a total of 10 wk. Mice in both groups appeared clinically normal. However, two mice in the NMMA group died during week 3 of treatment, leaving seven mice in the NMMA group for analysis. Extensive autopsies (including careful histological examinations and culturing of serum, urine, and organs) on these two mice and on a corn- The top portion shows the results from the x-ray film after probing with the cDNA. The bottom portion disphys the same falter after removing tl~ iNOS cDNA prose, and reanalyzing with a probe for 28S RNA as an indication of the equality of mRNA loading.
parable mouse that had received NMMA for 4 wk revealed no evidence of microbial infection or other evident cause of death. As shown in Fig. 6 A, administration of NMMA in the drinking water of MRL-lpr/lpr mice effectively blocked nitrate/nitrite excretion (and by inference nitric oxide production). Also, mice receiving NMMA excreted significantly less protein than did control mice; this difference became apparent at week 5 of treatment (Fig. 6 B) . Pathologic examination of the kidneys and knee joints of mice from the two groups of mice revealed significantly less disease in the NMMA-treated group. Renal disease as measured by the renal score, and arthritis as measured by the synovial score were both significantly less in the NMMA group as compared with the control group (Hg. 7). There was minimal to no glomerular proliferation in mice treated with NMMA, while all but one of the control mice had significant glomerular proliferation and hyperlobulation. The chronic interstitial lymphocytic infiltrate seen in the kidneys of all Ipr congenic mice (induding C3H-lpr/Ipr mice that do not develop glomerulonephritis) was present to comparable degrees in both control and NMMA-treated mice. Medium vessel vasculitis appears sporadicaUy in the kidneys of tmtreated MRLlpr/Ipr mice with an overall incidence of 30% (40) . Mild to moderate (1-2 +) medium vessd vasculitis was present in 3 of 10 kidneys from mice in the control group. Mild vasculitis was seen in 1 of 7 kidneys from the NMMA-treated group. proliferation was significantly decreased in the mice treated with NMMA (Fig. 7) . While only 3 of 7 mice in the NMMAtreated Stoup had abnormal kneejoints with mild to moderate syaovial proliferation and synovial inflammation, all 10 mice in the control water group had some degree of synovial prolifzration and inRammation. Levels of serum anti-doublestranded DNA measured at age 18 wk in the two groups were essentially equivalent (Fig. 7) .
Mouse Clm~s~ttomal Localization and Fine Mapping. To determine the chromosomal location of the gem encoding iNOS (designated N~) and its relationship to disease susceptibility genes, we analyzed a panel of DNA samples from an intmped~ cross that has been ~h=,-zterized fi~r over S00 genetic Nosi locus cosegregated with the erythroblastosis hydroxylase locus (Erba), a locus previously mapped to distal mouse chromosome 11 in this cross (Fig. 8 A) (43) . The best gene order plus or minus the standard deviation (35, 36) indicated the following relationships from proximal to distal:
Trp53-2.6 • 1.5 cM-Nosi-2.6 + 1.5 cM-Erbb2/Erba (Fig. 8 B) .
Di~u~on
We demonstrate here that MRL-ipr/ltrr mice spontaneously excrete high levels of urinary nitrite/nitrate that correspond temporally to the expression of inflammatory disease. Because there is no source of ingested nitrite/nitrate, the urinary nitrite/nitrate represents an oxidation product of NO. MRLIpr/Ipr mice also have increased expression iNOS mRNA and of the functional enzyme NOS, and by immunofluorescence and immunoblot assays, they display increased amounts of iNOS antigen in spleen and kidney. Furthermore, treatment with oral NMMA either prevented or significantly decreased clinical autoimmune disease (glomerulonephritis and arthritis), without altering serum levels of anti-DNA antibodies. This result indicates that NO is a critical mediator in the development of the inflammation characteristic of lpr disease, and that its production is not simply a reflection of nonspecific immune activation. The efficacy of NMMA suggests that treatments to reduce NO production or NO actions will be beneficial in inflammatory diseases. The cause(s) for the high levels of iNOS expression and NO production is not known. Mice with various infections have increased NO production (11, 12, 23) . Although it is possible that the MRL-Ipr/lpr mice had a subclinical infection, we feel this is unlikely since they were housed in identical conditions to control strains that had normal nitrate excretion, they had no serological evidence of viral or mycoplasmal infection, and they did not appear to be clinically infected.
MRL-Ipr/llYr mice have been shown before to display various parameters of macrophage activation (4) (5) (6) (7) (8) , possibly reflecting high levels ofcytokines that may "activate" the macrophages within these animals. The main cytokines thought to be involved are IFN-% TNF, and IL-1 (4-7). These cytokines are responsible for increasing iNOS and inducing NO production in vivo (10) (11) (12) Other investigators have noted that NO produced by macrophages or pancreatic beta cells is capable of destroying the beta cells and contributing to the development of insulindependent diabetes mellitus (52-54). Kleemann et al. (55) showed that adult rats of the insulin-dependent diabetes-prone strain BB have pancreases that display iNOS mRNA and protein coincident with macrophage infiltration and insulinitis, whereas normal rats do not. In a mouse model for insulindependent diabetes mdlitus (the NOD mouse [56] ), researchers have found various genes that influence the development of diabetes. NOD mice have features of an autoimmune disease including anti-islet call antibodies and defects in T cell activity. Several genetic susceptibility loci have been mapped; these include areas in the major histocompatibility complex in mouse chromosome 17, and sites on chromosomes 1, 3, and 11 (52, 53) . The ldd-5 gene maps to a region on chromosome 1 that includes the genes for the IL-1 receptor and the Beg locus (53) . The Beg locus determines the natural resistance (mediated by macrophages) of mice to infection with intracellular microorganisms such as mycohacteria and listeria.
Recently, a strong candidate for Bcg has been isolated and determined to encode a protein with structural homology to membrane proteins that serve to transport nitrate (57) . Vidal et al. (57) have found defects in this gene in mice of strains that lack resistance to infection, and they have postulated that these defects might interrupt a system that allows eifector ceils to accumulate nitrate for conversion to NO, and thus be important in microbial killing. Idd-4, a gene that influences the age at which NOD mice develop diabetes, maps to a region on chromosome 11 (58) that corresponds to the region where we map the gene for iNOS. Therefore, we suggest that iNOS is a strong candidate for an insulin dependent diabetes susceptibility gene. In two autoimmune diseases (that of NOD mice and that of MtLL-lpr/lpr mice), there are provocative relationships to NO and NOS. NO could act as an effector in promoting inflammation in these mice. Possible proinflammatory effects of NO include an ability to increase vascular permeability in inflamed tissues (18) , the secondary generation of destructive free radicals such as peroxynitrite and hydroxyl radical (15) (16) (17) , and the induction of the inflammatory cytokines TNF and IL-1 (13, 14) . Faneil et al. (21) demonstrated that humans with rheumatoid arthritis and ostcoarthritis had increased levels of the NO catabolite nitrite in their synovial fluids and in their sera, suggesting a similar state of increased NO production as in mice with immune inflammation and arthritis. The regional or systemic use of agents that can inhibit the action of NO (e.g., heme-containing compounds such as hemoglobin or myoglobin [12] , or agents that can block the production of NO (e.g., the iNOS inhibitor NMMA [22, 39, 50, 51] we used here) could be valuable in therapy in humans with diseases such as systemic lupus erythematosus, rheumatoid arthritis, or insulin-dependent diabetes meilitus. 
